Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Biomaterials
|
June 23, 2009
Induction of cartilage integration by a chondrocyte/collagen-scaffold implant
Moreica B Pabbruwe, Ehsanollah Esfandiari, Wael Kafienah, et al.
Dermatology and Therapy
|
September 6, 2025
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis
Emma Guttman-Yassky, Eric Simpson, Ehsanollah Esfandiari, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2006
TRACP Influences Th1 pathways by affecting dendritic cell function
Ehsanollah Esfandiari, Michael Bailey, Christopher R Stokes, et al.
Clinical and Translational Science
|
March 2, 2021
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects
Ehsanollah Esfandiari, Mary Chen, Glennda Smithson, et al.
Scientific Reports
|
January 10, 2018
Defining Phenotypes in Diabetic Nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort
Rosa M Montero, Athula Herath, Ashfaq Qureshi, et al.
American Journal of Clinical Dermatology
|
January 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology
|
February 10, 2024
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
Archives of Dermatological Research
|
November 6, 2024
Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab
Emma Guttman-Yassky, Ehsanollah Esfandiari, Hirotaka Mano, et al.
The British Journal of Dermatology
|
October 4, 2024
Content evaluation of pruritus, skin pain and sleep disturbance patient-reported outcome measures for adolescents and adults with moderate-to-severe atopic dermatitis: qualitative interviews
Andrew Blauvelt, Jennifer Reckleff, Yang Zhao, et al.
Advances in Therapy
|
January 7, 2024
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
Emma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Biomaterials
|
June 23, 2009
Induction of cartilage integration by a chondrocyte/collagen-scaffold implant
Moreica B Pabbruwe, Ehsanollah Esfandiari, Wael Kafienah, et al.
Dermatology and Therapy
|
September 6, 2025
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis
Emma Guttman-Yassky, Eric Simpson, Ehsanollah Esfandiari, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2006
TRACP Influences Th1 pathways by affecting dendritic cell function
Ehsanollah Esfandiari, Michael Bailey, Christopher R Stokes, et al.
Clinical and Translational Science
|
March 2, 2021
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects
Ehsanollah Esfandiari, Mary Chen, Glennda Smithson, et al.
Scientific Reports
|
January 10, 2018
Defining Phenotypes in Diabetic Nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort
Rosa M Montero, Athula Herath, Ashfaq Qureshi, et al.
American Journal of Clinical Dermatology
|
January 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology
|
February 10, 2024
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
Archives of Dermatological Research
|
November 6, 2024
Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab
Emma Guttman-Yassky, Ehsanollah Esfandiari, Hirotaka Mano, et al.
The British Journal of Dermatology
|
October 4, 2024
Content evaluation of pruritus, skin pain and sleep disturbance patient-reported outcome measures for adolescents and adults with moderate-to-severe atopic dermatitis: qualitative interviews
Andrew Blauvelt, Jennifer Reckleff, Yang Zhao, et al.
Advances in Therapy
|
January 7, 2024
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
Emma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Page
of 2